Charting the Future of COVID-19: Is “Back to Normal” Within Reach?

Published on
January 25th, 2021
Duration
68 minutes


Charting the Future of COVID-19: Is “Back to Normal” Within Reach?

The Interview ·
Featuring Justin Stebbing and James Rasteh

Published on: January 25th, 2021 • Duration: 68 minutes

How effective are the different COVID-19 vaccines? How does the science suggest we best move forward – and when will the world itself be rid of this deadly disease? In this interview, James Rasteh, founder and chief investment officer of Coast Capital, welcomes Justin Stebbing, professor of Cancer Medicine and Oncology at the Imperial College of London, to explore these critical questions. Stebbing gives a rigorous overview of the unique transmissibility and fatality rates of the virus and how the efficacies of the various vaccines, which are generally high, mean that a “back to normal” scenario is somewhat likely by around April 2021. Nevertheless, Stebbing thinks it is will be extremely difficult to eradicate COVID-19 completely and that, simply put, “coronavirus is here to stay.” Filmed on January 20, 2021. Key learnings: The plurality of highly-efficacious vaccines means a return to normal is within sight. But yearly booster shots will likely be required, and full eradication will be extremely difficult—if not impossible.